More than 14 years’ progress free survival of neratinib monotherapy for human epidermal growth factor receptor 2 (HER2) positive advanced breast cancer: a case report

Authors:
  • FLFeng Li
    Feng Li

Abstract
More than 14 years’ progress free survival of neratinib monotherapy for human epidermal growth factor receptor 2 (HER2) positive advanced breast cancer: a case report Lina Zhang, Shaohua Zhang, Yang Yuan, Jianbin Li, Feng Li, Cuizhi Geng, Zefei Jiang